These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

882 related items for PubMed ID: 3112230

  • 21. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY, Singleton A, Cillari E, Howard JG.
    J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
    [Abstract] [Full Text] [Related]

  • 22. Selective production of interleukin 3 (IL3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro by murine L3T4+ T cells: lack of spontaneous IL3 and GM-CSF production by Ly-2-/L3T4- lpr subset.
    Davignon JL, Kimoto M, Kindler V, De Kossodo S, Vassalli P, Izui S.
    Eur J Immunol; 1988 Sep; 18(9):1367-72. PubMed ID: 3139430
    [Abstract] [Full Text] [Related]

  • 23. Immunity to experimental infection with Leishmania major: generation of protective L3T4+ T cell clones recognizing antigen(s) associated with live parasites.
    Müller I, Louis JA.
    Eur J Immunol; 1989 May; 19(5):865-71. PubMed ID: 2500348
    [Abstract] [Full Text] [Related]

  • 24. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
    Scharton-Kersten T, Afonso LC, Wysocka M, Trinchieri G, Scott P.
    J Immunol; 1995 May 15; 154(10):5320-30. PubMed ID: 7730635
    [Abstract] [Full Text] [Related]

  • 25. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
    Holaday B, Sadick MD, Pearson RD.
    J Immunol; 1988 Sep 15; 141(6):2132-7. PubMed ID: 3262649
    [Abstract] [Full Text] [Related]

  • 26. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype.
    Uzonna JE, Kaushik RS, Gordon JR, Tabel H.
    J Immunol; 1998 Nov 15; 161(10):5507-15. PubMed ID: 9820527
    [Abstract] [Full Text] [Related]

  • 27. A role for gamma delta + T cells during experimental infection of mice with Leishmania major.
    Rosat JP, MacDonald HR, Louis JA.
    J Immunol; 1993 Jan 15; 150(2):550-5. PubMed ID: 8419488
    [Abstract] [Full Text] [Related]

  • 28. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
    Murray HW, Stern JJ, Welte K, Rubin BY, Carriero SM, Nathan CF.
    J Immunol; 1987 Apr 01; 138(7):2290-7. PubMed ID: 3104456
    [Abstract] [Full Text] [Related]

  • 29. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis.
    Titus RG, Milon G, Marchal G, Vassalli P, Cerottini JC, Louis JA.
    Eur J Immunol; 1987 Oct 01; 17(10):1429-33. PubMed ID: 3119350
    [Abstract] [Full Text] [Related]

  • 30. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M.
    J Immunol; 1996 Jan 15; 156(2):644-52. PubMed ID: 8543816
    [Abstract] [Full Text] [Related]

  • 31. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY, Dhaliwal JS.
    J Immunol; 1987 Jun 15; 138(12):4450-6. PubMed ID: 3295049
    [Abstract] [Full Text] [Related]

  • 32. Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors.
    Nylén S, Maasho K, McMahon-Pratt D, Akuffo H.
    Scand J Immunol; 2004 Mar 15; 59(3):294-304. PubMed ID: 15030581
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice.
    Wofsy D, Mayes DC, Woodcock J, Seaman WE.
    J Immunol; 1985 Sep 15; 135(3):1698-701. PubMed ID: 3160776
    [Abstract] [Full Text] [Related]

  • 34. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M, Rivera-Montoya I, Espinoza A, Romero-Grijalva M, López-Flores R, González J, Terrazas LI.
    Cell Immunol; 2006 Aug 15; 242(2):61-71. PubMed ID: 17118349
    [Abstract] [Full Text] [Related]

  • 35. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH, Campos-Neto A, Reed SG.
    J Immunol; 1998 Dec 01; 161(11):6171-9. PubMed ID: 9834103
    [Abstract] [Full Text] [Related]

  • 36. T cell response in murine Leishmania mexicana amazonensis infection: production of interferon-gamma by CD8+ cells.
    Chan MM.
    Eur J Immunol; 1993 May 01; 23(5):1181-4. PubMed ID: 8097471
    [Abstract] [Full Text] [Related]

  • 37. Kinetics of cell-mediated immunity developing during the course of Leishmania major infection in 'healer' and 'non-healer' mice: progressive impairment of response to and generation of interleukin-2.
    Solbach W, Lohoff M, Streck H, Rohwer P, Röllinghoff M.
    Immunology; 1987 Nov 01; 62(3):485-92. PubMed ID: 3499384
    [Abstract] [Full Text] [Related]

  • 38. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts.
    Heinzel FP, Rerko RM, Hatam F, Locksley RM.
    J Immunol; 1993 May 01; 150(9):3924-31. PubMed ID: 8473741
    [Abstract] [Full Text] [Related]

  • 39. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C, Schröppel K, Lohoff M, Röllinghoff M, Solbach W.
    Eur J Immunol; 1990 Dec 01; 20(12):2533-40. PubMed ID: 1980108
    [Abstract] [Full Text] [Related]

  • 40. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S, Soto M, Carrión J, Alonso C, Requena JM.
    Vaccine; 2004 Sep 28; 22(29-30):3865-76. PubMed ID: 15364433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.